In this study, we further examined effects of chronic inhibition of NKCC1 activation via BMT or STS66 on WNK1-SPAK/OSR1-NKCC1 signaling pathway in glioma cells in response to TMZ. This evidence concerns the gene WNK1 and central nervous system cancer.